Preclinical Evaluation of New Taxoids

E-ISSN： 1873-4286|7|13|1251-1257

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.13, 2001-09, pp. : 1251-1257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Evaluation of New Anthracyclines

Current Medicinal Chemistry, Vol. 8, Iss. 1, 2001-01 ,pp. : 9-13

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments in antitumour taxoids

By Dubois Joëlle Guénard Daniel Guéritte Françoise

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 12, 2003-12 ,pp. : 1809-1823

Informa Healthcare

Access to resources Recommend Favorite

Preclinical Safety Evaluation of Recombinant Human Interleukin-10

By Rosenblum I.Y. Johnson R.C. Schmahai T.J.

Regulatory Toxicology and Pharmacology, Vol. 35, Iss. 1, 2002-02 ,pp. : 56-71

Elsevier

Access to resources Recommend Favorite

Preclinical studies with new pyrrolidine platinum(II) compounds

By Sampedro F. van Haperen V.R. Izquierdo M. Vicens M. Santalo P. Pueyo M. Llagostera M. Marcuello E. De Andres L.

European Journal of Medicinal Chemistry, Vol. 30, Iss. 6, 1995-01 ,pp. : 497-501

Elsevier

Access to resources Recommend Favorite

Preclinical evidence of new opioid modulators for the treatment of addiction

By Rodríguez-Arias Marta Aguilar María Asunción Manzanedo Carmen Miñarro José

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 977-994

Informa Healthcare

Access to resources Recommend Favorite